Items tagged with HIV coinfection
IAS webinar: HIV and TB co-infections: Latest updates and innovations (post)
On 4 April 2023, the International AIDS Society (IAS) will host a webinar that will provide updates on innovations in the treatment and prevention of HIV and TB co-infections, including the World Health Organization’s recently published module in its consolidated guidelines on TB: Drug-resistant tuberculosis treatment 2022 update.
The part we often forget: Care for children and teens with advanced HIV disease (post)
A new article in the Journal of the International AIDS Society highlights the urgent need for a clear strategy to prevent and treat advanced HIV disease in children and teens.
TB disease intensifies HIV antibody response in people with HIV (post)
BOSTON – New research from Boston Medical Center found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody resistant as compared to those without suspected or documented tuberculosis. Published in iScience, the study suggests that concomitant tuberculosis disease has a significant impact on HIV immune responses and the viruses circulating in people living with HIV.
Once-daily dolutegravir sufficient when taking TB treatment (post)
A second daily dose of dolutegravir for people taking standard TB treatment seems to be unnecessary, a South African randomised study has reported in the journal Lancet HIV.
Earlier antiretroviral treatment has led to a major decline in TB among people with HIV in Switzerland (post)
Rising CD4 counts and suppressed viral load on antiretroviral treatment have had a far greater impact on reducing new cases of tuberculosis (TB) in people with HIV in Switzerland than testing and preventive treatment for latent TB, researchers from the Swiss HIV Cohort report in the journal Clinical Infectious Diseases.
Why hunger is driving thousands to abandon the drugs that keep them alive (post)
Crippling hunger has driven Vitola Genti to the brink. The 67-year-old, a refugee in Malawi, has HIV and is dependent on antiretroviral drugs to keep the virus dormant in her body.
Increased risk of all-cause mortality in co-occurring diabetes, HIV during TB treatment (post)
Mortality risk was higher for patients with concurrent diabetes and TB infection and more common than HIV and TB coinfection.
Incidence rate of TB among individuals with HIV in Africa higher than estimated (post)
The World Health Organization 2022 Africa regional report underestimated the incidence rate of tuberculosis in sub-Saharan African individuals living with HIV, according to a recent analysis.
PEPFAR launches new effort to fight TB: Goal to detect two million cases and prevent 500,000 deaths (post)
22 September 2023: Today, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) launched an effort to detect two million active tuberculosis (TB) cases over the next five years and prevent at least 500,000 TB-related deaths among people living with HIV. According to estimates, more than half of the current TB cases among people living with HIV go undiagnosed. PEPFAR and its partners are committed to using new tools and new approaches that dramatically increase TB diagnosis and treatment coverage for people living with HIV.
Very poor long-term outcomes for people with TB and HIV in Eastern Europe (post)
The rates of tuberculosis (TB) recurrence and mortality in people with HIV in eastern Europe remain concerningly high and continue to be a clinical and public health challenge, according to a paper published in AIDS. In the first study to report on long-term follow-up of TB/HIV co-infected patients in eastern Europe, one in seven people had TB again and over half died.
Page 41 of 52 · Total posts: 0
←First 40 41 42 Last→